Luo Xin Pharmaceutical: Controlling shareholder receives 130 million yuan capital increase and completes business registration.

Loyin Pharmaceutical announced that on July 16, 2025, the controlling shareholder Loyin Holdings agreed to a capital increase of 130 million yuan by the New and Old Energy Fund, subscribing to an additional registered capital of 52 million yuan. Shareholders including Liu Baoqi gave up their subscription rights. After the capital increase, the registered capital of Loyin Holdings increased from 200 million yuan to 252 million yuan, with no change in the number of company shares held and the shareholding ratio. Recently, the capital increase has been completed and registered with the business administration, and Loyin Holdings has obtained a new business license.